You are here

NMIBC

Merck's Blockbuster Drug Wins Key New FDA Approval

Motley Fool

Thu, 01/9/20 - 10:57 am

Merck’s Keytruda nabs FDA panel's favor to line up for new bladder cancer OK

Fierce Pharma

Wed, 12/18/19 - 10:50 am

FerGene’s Bladder Cancer Phase III Trial Hits Its Mark

BioSpace

Fri, 12/6/19 - 10:09 am

Ferring Pharmaceuticals

Blackstone Life Sciences

clinical trials

Merck's Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?

Fierce Pharma

Tue, 12/3/19 - 10:42 pm

nadofaragene firadenovec

Merck’s Keytruda gets FDA priority review for high-risk NMIBC

Pharmaceutical Business Review

Mon, 12/2/19 - 10:46 am

priority review